Design, Synthesis, and Molecular Docking Studies of Curcumin Hybrid Conjugates as Potential Therapeutics for Breast Cancer
Curcumin (CUR) has received great attention over the past two decades due to its anticancer, anti-inflammatory, and antioxidant properties. Similarly, Dichloroacetate (DCA), an pyruvate dehydrogenase kinase 1 (PKD1) inhibitor, has gained huge attention as a potential anticancer drug. However, the cl...
Saved in:
Main Authors: | Siva S. Panda (Author), Queen L. Tran (Author), Pragya Rajpurohit (Author), Girinath G. Pillai (Author), Sean J. Thomas (Author), Allison E. Bridges (Author), Jason E. Capito (Author), Muthusamy Thangaraju (Author), Bal L. Lokeshwar (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Molecular Docking of Curcumin With Breast Cancer Cell Line Proteins
by: Asita Elengoe, et al.
Published: (2020) -
Molecular docking analysis of curcumin analogues as human neutrophil elastase inhibitors
by: Radhakrishnan Narayanaswamy, et al.
Published: (2014) -
Degree-based topological indices and polynomials of hyaluronic acid-curcumin conjugates
by: Parvez Ali, et al.
Published: (2020) -
Evaluation of polymeric PLGA nanoparticles conjugated to curcumin for use in aPDT
by: Renata Celi Carvalho de Souza Pietra, et al.
Published: (2017) -
Design, Synthesis, Molecular Docking, and Biological Evaluation of Pyrazole Hybrid Chalcone Conjugates as Potential Anticancer Agents and Tubulin Polymerization Inhibitors
by: Md. Jahangir Alam, et al.
Published: (2022)